GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Beijing Strong Biotechnologies Inc (SZSE:300406) » Definitions » Market Cap

Beijing Strong Biotechnologies (SZSE:300406) Market Cap : ¥8,678 Mil (As of Dec. 15, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Beijing Strong Biotechnologies Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Beijing Strong Biotechnologies's share price for the quarter that ended in Sep. 2024 was ¥14.85. Beijing Strong Biotechnologies's Shares Outstanding (EOP) for the quarter that ended in Sep. 2024 was 588 Mil. Therefore, Beijing Strong Biotechnologies's market cap for the quarter that ended in Sep. 2024 was ¥8,738 Mil.

Beijing Strong Biotechnologies's quarterly market cap declined from Mar. 2024 (¥11,357 Mil) to Jun. 2024 (¥9,050 Mil) and declined from Jun. 2024 (¥9,050 Mil) to Sep. 2024 (¥8,738 Mil).

Beijing Strong Biotechnologies's annual market cap declined from Dec. 2021 (¥11,674 Mil) to Dec. 2022 (¥9,639 Mil) but then increased from Dec. 2022 (¥9,639 Mil) to Dec. 2023 (¥11,239 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Beijing Strong Biotechnologies's Enterprise Value for Today is ¥8,855 Mil.


Beijing Strong Biotechnologies Market Cap Historical Data

The historical data trend for Beijing Strong Biotechnologies's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Strong Biotechnologies Market Cap Chart

Beijing Strong Biotechnologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8,159.07 14,736.70 11,673.66 9,639.34 11,239.32

Beijing Strong Biotechnologies Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11,757.13 11,239.32 11,357.01 9,050.30 8,738.42

Competitive Comparison of Beijing Strong Biotechnologies's Market Cap

For the Diagnostics & Research subindustry, Beijing Strong Biotechnologies's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Strong Biotechnologies's Market Cap Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Beijing Strong Biotechnologies's Market Cap distribution charts can be found below:

* The bar in red indicates where Beijing Strong Biotechnologies's Market Cap falls into.



Beijing Strong Biotechnologies Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Beijing Strong Biotechnologies's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=¥19.1*588.446
=¥11,239

Beijing Strong Biotechnologies's Market Cap for the quarter that ended in Sep. 2024 is calculated as

Market Cap (Q: Sep. 2024 )=Share Price (Q: Sep. 2024 )*Shares Outstanding (EOP) (Q: Sep. 2024 )
=¥14.85*588.446
=¥8,738

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beijing Strong Biotechnologies  (SZSE:300406) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Beijing Strong Biotechnologies Market Cap Related Terms

Thank you for viewing the detailed overview of Beijing Strong Biotechnologies's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Strong Biotechnologies Business Description

Traded in Other Exchanges
N/A
Address
No. 15 Hua Yuan Dong Lu, 5th Floor, Kuang Yi Building, Haidian District, Beijing, CHN, 100191
Beijing Strong Biotechnologies Inc is a China-based provider of in-vitro (IVD) diagnostics products and service. The company is engaged in the research, development, production, and sale of IVD products. It also provides diversified clinical diagnosis solutions to customers. Its products include clinical biochemistry testing, coagulation testing, blood typing, serology and automated blood grouping analyzer. The firm has established a clinical biochemistry platform of the enzymatic method (including enzymatic cycling method), immunoturbidimetric method, and latex immunoturbidimetric method.
Executives
Shuang He Executives
Luo Ai Ping Director
Directors, executives
Liu Wei Executives
Zhou Ming Executives
Zhuang Xian Min Directors, executives
Zhang Yi Executives
Liu Xi Directors, executives
Sun Xiao Lin Director
Yu Jian Ping Executives

Beijing Strong Biotechnologies Headlines

No Headlines